#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15108	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2030	733.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1401	1401	C	803	C	777	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27896	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3528	784.0	0	.	n	.	0	T695C	SNP	695	695	T	975	975	C	883	C	863	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27896	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3528	784.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1617	1617	A	950	A,G	926,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27896	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3528	784.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2251	2251	C	889	C,G	856,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27896	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3528	784.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2325	2325	A	818	A,G	801,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27896	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3528	784.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2877	2877	C	841	C	814	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27896	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3528	784.0	0	HET	.	.	.	A790G	.	790	790	A	1070	1070	A	856	A,G	484,344	.	.
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	1780	folP	855	855	100.0	folP.l15.c4.ctg.1	1517	116.1	1	SNP	p	R229S	0	.	.	685	687	CGC	984	986	CGC	177;179;179	C;G;C	168;172;174	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5066	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3413	147.3	1	SNP	p	S91F	0	.	.	271	273	TCC	576	578	TCC	204;204;206	T;C;C	199;199;200	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5066	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3413	147.3	1	SNP	p	D95G	0	.	.	283	285	GAC	588	590	GAC	206;204;203	G;A;C	197;193;196	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5066	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3413	147.3	1	SNP	p	D95N	0	.	.	283	285	GAC	588	590	GAC	206;204;203	G;A;C	197;193;196	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	1612	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1272	125.4	1	SNP	p	G45D	1	.	.	133	135	GAC	447	449	GAC	181;182;181	G,T;A;C	180,1;176;180	mtrR.WHO_L_00489c:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	894	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1103	80.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	4728	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2802	166.9	1	SNP	p	D86N	0	.	.	256	258	GAC	491	493	GAC	200;201;203	G;A;C	196;190;198	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	4728	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2802	166.9	1	SNP	p	S88P	0	.	.	262	264	TCC	497	499	TCC	198;197;198	T,G;C;C	184,1;193;192	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3958	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2566	152.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1450	1452	GGC	175;171;171	G;G;C	171;167;158	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.43.002	penA.43.002	1	1	539	3704	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2545	144.2	0	.	p	.	0	P552L	NONSYN	1654	1656	CCG	2094	2096	CTG	117;118;115	C,G;T;GCCC,GCCCC	99,5;91;85,1	.	.
penA.43.002	penA.43.002	1	1	539	3704	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2545	144.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1371	1373	GCA	219;218;220	G;C;A	209;204;212	penA.43.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	3704	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2545	144.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1374	1376	ATC	219;218;220	A;T;C,A	210;205;211,1	penA.43.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	3704	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2545	144.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1386	1388	GTG	216;212;208	G;T,G,C,A;G	213;199,1,1,1;206	penA.43.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	3704	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2545	144.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1386	1388	GTG	216;212;208	G;T,G,C,A;G	213;199,1,1,1;206	penA.43.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	3704	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2545	144.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1890	1892	ACC	179;178;177	A,C;C;C	159,2;173;172	penA.43.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	3704	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2545	144.2	1	SNP	p	V502P	0	.	.	1504	1506	GTG	1944	1946	GTG	172;170;173	G;T,G;G	166;133,10;167	penA.43.002:1:1:V502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	3704	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2545	144.2	1	SNP	p	A502V	1	.	.	1504	1506	GTG	1944	1946	GTG	172;170;173	G;T,G;G	166;133,10;167	penA.43.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	3704	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2545	144.2	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2067	2069	GGC	125;127;124	G;G;C	117;120;118	penA.43.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.43.002	penA.43.002	1	1	539	3704	penA	1749	1749	99.94	penA.l6.c4.ctg.1	2545	144.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2076	2078	GGC	116;115;114	G;G,T;C	114;111,1;111	penA.43.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	5466	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3051	177.8	1	SNP	p	L421P	1	L421P	NONSYN	1261	1263	CTG	1610	1612	CCG	175;174;175	C;C,A;G,A,C	164;171,1;169,1,1	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2178	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1961	110.0	0	.	p	.	0	S22G	NONSYN	64	66	AGC	447	449	GGC	137;136;136	G;G;C	129;128;127	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2178	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1961	110.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	629	629	C	153	C	144	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2830	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1597	175.6	0	.	p	.	0	G120N	NONSYN	358	360	GGC	755	757	AAC	232;230;231	A;A;C	221;221;225	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2830	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1597	175.6	0	.	p	.	0	E212G	NONSYN	634	636	GAA	1031	1033	GGA	220;223;221	G;G;A	217;220;209	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2830	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1597	175.6	0	.	p	.	0	Y216_S217del	DEL	646	646	T	1043	1043	T	211	T	211	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2830	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1597	175.6	0	.	p	.	0	D294N	NONSYN	880	882	GAT	1271	1273	AAT	239;242;240	A;A;T,A	226;233;228,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2830	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1597	175.6	1	SNP	p	A121D	1	.	.	361	363	GAC	758	760	GAC	235;233;235	G;A;C	226;224;225	porB1b.WHO_P_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2830	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1597	175.6	1	SNP	p	D121N	0	.	.	361	363	GAC	758	760	GAC	235;233;235	G;A;C	226;224;225	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10304	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4799	212.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1178	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	970	118.7	1	SNP	p	V57M	1	.	.	169	171	ATG	513	515	ATG	240;241;239	A;T;G	236;237;237	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
